Nuts and Bolts of Fecal Microbiota Transplantation.
Clostridium difficile
FMT
fecal transplant
microbiome
Journal
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
ISSN: 1542-7714
Titre abrégé: Clin Gastroenterol Hepatol
Pays: United States
ID NLM: 101160775
Informations de publication
Date de publication:
01 2019
01 2019
Historique:
received:
24
05
2018
revised:
14
09
2018
accepted:
19
09
2018
pubmed:
1
10
2018
medline:
11
3
2020
entrez:
1
10
2018
Statut:
ppublish
Résumé
Clostridium difficile infection (CDI) has become the leading cause of nosocomial infection in the United States with significant risk of both morbidity and mortality. While antimicrobial therapy forms the basis of treatment, there are several clinical scenarios in which antimicrobial therapy alone is insufficient. Evidence continues to show the safety and efficacy fecal microbiota transplantation (FMT) in recurrent and severe CDI. This review will outline FMT efficacy, safety, and indications and present practical advice for clinicians interested in best practices around delivery of FMT.
Identifiants
pubmed: 30268564
pii: S1542-3565(18)31020-6
doi: 10.1016/j.cgh.2018.09.029
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
345-352Informations de copyright
Copyright © 2019 AGA Institute. Published by Elsevier Inc. All rights reserved.